Barclays upgraded Deutsche Bank from Equal Weight to Overweight
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/3/2024 | Equal Weight → Overweight | Barclays | |
| 3/27/2024 | Equal-Weight → Overweight | Morgan Stanley | |
| 1/31/2024 | Buy → Neutral | Citigroup | |
| 9/22/2023 | Equal-Weight | Morgan Stanley | |
| 7/10/2023 | Buy → Hold | Societe Generale | |
| 5/4/2023 | Neutral → Buy | Citigroup | |
| 2/13/2023 | Neutral → Underperform | BofA Securities | |
| 11/25/2022 | Sector Perform → Outperform | RBC Capital Mkts |
Barclays upgraded Deutsche Bank from Equal Weight to Overweight
Morgan Stanley upgraded Deutsche Bank from Equal-Weight to Overweight
Citigroup downgraded Deutsche Bank from Buy to Neutral
424B3 - DEUTSCHE BANK AKTIENGESELLSCHAFT (0001159508) (Filer)
6-K - DEUTSCHE BANK AKTIENGESELLSCHAFT (0001159508) (Filer)
6-K - DEUTSCHE BANK AKTIENGESELLSCHAFT (0001159508) (Filer)
SC 13G/A - DEUTSCHE BANK AKTIENGESELLSCHAFT (0001159508) (Subject)
SC 13G - DEUTSCHE BANK AKTIENGESELLSCHAFT (0001159508) (Subject)
NEW YORK, April 13, 2022 (GLOBE NEWSWIRE) -- Apollo (NYSE:APO) today announced that funds managed by Apollo affiliates (the "Apollo Funds") have completed the acquisition of a majority stake in Novolex Holdings LLC ("Novolex" or the "Company"), a leading global manufacturer of diverse and sustainable packaging products for the foodservice, delivery and carryout, food processor and industrial markets, from funds managed by Carlyle (NASDAQ:CG). Carlyle will retain a minority stake in the Company. The financing for the acquisition includes the largest-ever sustainability-linked loan issued to date. Additional financial terms of the transaction were not disclosed. Stan Bikulege, Novolex Chai
Star Mountain Capital, a rapidly growing employee-owned specialized investment firm with over $3.5 billion AUM, focused on delivering systematic alpha and low market correlated returns from high yielding private loans with equity upside in the lower middle-market, announced that Eric Kirsch has joined as Senior Advisor. Star Mountain Capital, LLC ("Star Mountain"), a specialized investment manager with over $3.5 billion in assets under management (committed capital including debt facilities as of 9/30/2023) focused on generating defensive and premium returns from the less efficient and labor-intensive market of U.S. private small and medium-sized businesses (the "lower middle-market"), is
LONDON and NEW YORK, April 19, 2021 /PRNewswire/ -- DirectBooks™, the capital markets consortium founded to optimize global financing markets, today announced the launch of Euro and Sterling Investment Grade deal announcements on the DirectBooks platform. The DirectBooks platform launched in Q4 2020 with deal announcement functionality for U.S. Dollar Investment Grade issuances globally, with a common set of structured deal data and document access for institutional investors. As part of its European expansion, DirectBooks also announced the appointment of Duncan Phillips as
Shares of General Dynamics Corporation (NYSE:GD) fell sharply during Wednesday's session after the company reported worse-than-expected second-quarter EPS results. Revenue for the quarter increased 18% year-over-year to $11.976 billion, beating the consensus of $11.438 billion. EPS of $3.26 (up 20.7% YoY) missed the consensus of $3.29, according to data from Benzinga Pro. General Dynamics shares declined 5.2% to $279.26 on Wednesday. Here are some other stocks moving in today’s mid-day session. Gainers NuZee, Inc. (NASDAQ:NUZE) jumped 192% to $3.01. Dermata Therapeutics, Inc. (NASDAQ:DRMA) rose 142.4% to $3.0799 after falling over 22% on Tuesday. Selina Hospitality PLC
U.S. stock futures were lower this morning, with the Nasdaq futures dipping around 200 points on Wednesday. Shares of Tesla, Inc. (NASDAQ:TSLA) fell sharply in today's pre-market trading following second-quarter results. Tesla reported second-quarter revenue of $25.5 billion, up 2% year-over-year. The revenue total beat a Street consensus estimate of $24.73 billion, according to data from Benzinga Pro. The company reported earnings per share of 52 cents in the second quarter, down 43% year-over-year. The earnings per share missed a Street consensus estimate of 62 cents per share. The company reported second-quarter deliveries of 443,956 vehicles and production of 410,831 vehicles, d
Deutsche Bank today announced that its New York Branch, Deutsche Bank New York (DBNY), and its affiliate Deutsche Bank Trust Company Americas (DBTCA) have decreased their prime lending from 8.00% to 7.75% effective tomorrow, November 8, 2024. About Deutsche Bank Deutsche Bank provides commercial and investment banking, retail banking, transaction banking and asset and wealth management products and services to corporations, governments, institutional investors, small and medium-sized businesses, and private individuals. Deutsche Bank is Germany's leading bank, with a strong position in Europe and a significant presence in the Americas and Asia Pacific. This release contains forward-looki
Deutsche Bank announced today its appointment as depositary bank for the NASDAQ-listed American Depositary Receipt program of WeRide Inc. WeRide Inc. (NASDAQ:WRD) provides autonomous driving products and services from Level 2 to Level 4, addressing transportation needs across a wide range of use cases on open road, including in mobility, logistics, and sanitation industries. Its corporate headquarters are located in Guangzhou, China.* In addition to specializing in administering cross-border equity structures such as New York Shares and American and Global Depositary Receipts, Deutsche Bank provides corporates, financial institutions, hedge funds and supranational agencies around the worl
Deutsche Bank announced today its appointment as depositary bank for the American Depositary Receipt program of Radiopharm Theranostics Limited. Radiopharm Theranostics Limited (OTC:RADTY) is a clinical stage radiotherapeutics company developing a world-class platform of innovative radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. Radiopharm has been listed on ASX (RAD) since November 2021. The company has a pipeline of distinct and highly differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer, in pre-clinical and clinical stages of development from some of the world's l